| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |